首页> 外文期刊>Surgical infections >Screening for Ventilator-Associated Pneumonia in the Surgical Intensive Care Unit: A Single-Institution Analysis of 1,013 Lower Respiratory Tract Cultures
【24h】

Screening for Ventilator-Associated Pneumonia in the Surgical Intensive Care Unit: A Single-Institution Analysis of 1,013 Lower Respiratory Tract Cultures

机译:在外科重症监护室筛查呼吸机相关性肺炎:1,013下呼吸道培养物的单机构分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Refinement of criteria for both screening and initiation of empiric therapy in ventilator-associated pneumonia (VAP) will minimize antibiotic overuse. We hypothesized that variables within the commonly used Clinical Pulmonary Infection Score (CPIS) have unfavorable test performance characteristics. Methods: Consecutive bronchoalveolar lavage (BAL) cultures obtained from surgical intensive care unit patients were abstracted (2009-2012). Ventilator-associated pneumonia was defined as 10(5) cfu/mL. The CPIS both without (CPISclinical) and with (CPISclinical+GS) the result of gram stain (GS) was calculated. Test performance characteristics for the sample, as well as several subgroups, were compared. Results: One thousand thirteen lower respiratory tract cultures from 492 patients were analyzed; 438 (43.2%) of cultures were classified as VAP, and 310 of 492 patients (62.4%) had 1 episode of VAP. Both CPISclinical and CPISclinical+GS had poor discrimination for VAP (Receiver-operating characteristic area under the curve=0.55 and 0.66, respectively). Sensitivity of CPISclinical using a threshold of >6 was 21%; the lowest threshold for CPISclinical for which the sensitivity was at least 85% was 3. The highest sensitivity among the individual CPIS components was new CXR infiltrate (91.1%). Among the subset of cultures sent during the early VAP window (days intubated 2-5), organisms on GS had a sensitivity of 93.3%. The CPISclinical, CPISclinical+GS, organisms, and neutrophils on GS parameters all became less accurate in both the late VAP window and when screening for recurrent VAP. Every case of VAP had at least one of the following: 1) fever; 2) new CXR infiltrate, or 3) organisms on GS. Conclusion: In this series of BALs, traditional screening tools for VAP missed the majority of microbiological confirmed cases. Screening based on either new CXR infiltrate or fever yielded an acceptably high sensitivity. The only scenario identified in which empiric antibiotics could be withheld safely was the absence of organisms on GS in the early VAP window.
机译:背景:完善呼吸机相关性肺炎(VAP)的筛查和开始经验治疗的标准将最大限度地减少抗生素的过度使用。我们假设常用的临床肺部感染评分(CPIS)中的变量具有不利的测试性能特征。方法:对2009-2012年从外科重症监护室患者获得的连续支气管肺泡灌洗液(BAL)进行提取。呼吸机相关性肺炎定义为10(5)cfu / mL。不使用(CPISclinical)和使用(CPISclinical + GS)的CPIS均计算出革兰氏染色(GS)的结果。比较了样品以及几个亚组的测试性能特征。结果:分析了492例患者的113种下呼吸道培养物。 438例(43.2%)培养物被归类为VAP,492例患者中的310例(62.4%)发生了1例VAP。 CPISclinical和CPISclinical + GS都对VAP的辨别能力较差(曲线下的接收器操作特征区域分别为0.55和0.66)。使用> 6的阈值对CPISclinical的敏感性为21%;对于CPIS临床,灵敏度至少为85%的最低阈值为3。在单个CPIS组件中,灵敏度最高的是新的CXR浸润(91.1%)。在早期VAP窗口期间(插管2-5天)发送的培养物子集中,对GS的生物的敏感性为93.3%。在晚期VAP窗口和筛查复发性VAP时,GS参数的CPISclinical,CPISclinical + GS,生物和中性粒细胞的准确性均下降。每例VAP至少具有以下一种:1)发烧; 2)新的CXR浸润,或3)GS上的生物。结论:在这一系列的BAL中,传统的VAP筛查工具漏掉了大多数微生物确诊病例。基于新的CXR浸润或发烧的筛查产生了可接受的高灵敏度。可以确定安全地停用经验性抗生素的唯一方案是在早期VAP窗口中GS上没有生物。

著录项

  • 来源
    《Surgical infections》 |2015年第4期|368-374|共7页
  • 作者单位

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

    Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80262 USA;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号